Gene · 4837
Papers1,489
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,489
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NNMT-driven metabolic reprogramming creates a NAMPT druggable vulnerability and reveals liquid biopsy biomarkers for TKI resistance in EGFR-mutant NSCLC. | Cancer Lett | 2025 | 40935282 | PubTator, text mining | PubMed |
| Urinary mRNA biomarkers for the noninvasive diagnosis of calcineurin inhibitor toxicity in kidney transplant recipients with graft dysfunction: a retrospective study. | Clin Transplant Res | 2025 | 40916802 | PubTator, text mining | PubMed |
| Joint Metabolomics and Transcriptomics Reveal Rewired Glycerophospholipid and Arginine Metabolism as Components of BRCA1-Induced Metabolic Reprogramming in Breast Cancer Cells. | Metabolites | 2025 | 40863152 | PubTator, text mining | PubMed |
| Nicotinamide N-methyltransferase enhances paclitaxel resistance in ovarian clear cell carcinoma. | Hum Cell | 2025 | 40853419 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals metastatic and immunosuppressive characteristics in meningioma brain-tumor interface. | J Transl Med | 2025 | 40826459 | PubTator, text mining | PubMed |
| NNMT enhances invasive and migratory capacity of keloid fibroblasts and M2 macrophage polarization. | Arch Biochem Biophys | 2025 | 40818625 | PubTator, text mining | PubMed |
| Understanding and targeting senescence in kidney disease. | Clin Kidney J | 2025 | 40761301 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
| Nicotinamide N-methyltransferase in non-alcoholic fatty liver disease: Mechanistic insights and emerging therapeutic strategies. | Arch Biochem Biophys | 2025 | 40706948 | PubTator, text mining | PubMed |
| Pericyte drives the formation of circulating tumour cell-neutrophil clusters to promote colorectal cancer metastasis. | Gut | 2025 | 40701795 | PubTator, text mining | PubMed |
| Replacing normalizations with interval assumptions enhances differential expression and differential abundance analyses. | BMC Bioinformatics | 2025 | 40597595 | PubTator, text mining | PubMed |
| Integrated-omics analysis defines subtypes of hepatocellular carcinoma based on circadian rhythm. | J Integr Med | 2025 | 40581550 | PubTator, text mining | PubMed |
| Prognostic and Therapeutic Value of Metabolism-Related Genes in Nephroblastoma: A Focus on the Key Gene NNMT and Its Regulative Effect on Metabolism. | Cell Biochem Funct | 2025 | 40574709 | PubTator, text mining | PubMed |
| SNORA13 antisense oligonucleotides enhances the therapeutical effects of 5-fluorouracil in colon adenocarcinoma. | Front Pharmacol | 2025 | 40529507 | PubTator, text mining | PubMed |
| NNMT-mediated N6-methyladenosine modification of NR4A3 mRNA facilitates lymphatic metastasis of gastric adenocarcinoma. | Oncogene | 2025 | 40523962 | PubTator, text mining | PubMed |
| A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance-A Role for Nicotinamide N-Methyltransferase. | Cells | 2025 | 40497995 | PubTator, text mining | PubMed |
| Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer. | Mol Cancer Ther | 2025 | 40497697 | PubTator, text mining | PubMed |
| Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets. | Biomolecules | 2025 | 40427612 | PubTator, text mining | PubMed |
| Strength and Conditioning Society (SCS) 7th Annual Meeting, Murcia, Spain, 2024. | Sports (Basel) | 2025 | 40423273 | PubTator, text mining | PubMed |
| Nicotinamide N-methyltransferase in cardiovascular Diseases: Mechanistic insights and therapeutic potential. | Eur J Med Chem | 2025 | 40412299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4837/papers?page=5